Down Sendromlu Erişkinde Myelodisplastik Sendrom: İyi Bilenen Bir Pediatrik Hastalığın Nadiren Görülmesi

Kaynakça (5)

1. Fong CT, Bordeur GM. Down’s syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet 1987;28:55-76
2. Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH. The changing survival profile of people with Down’s syndrome: implications for genetic counselling. Clin Genet 2002;62:390-393
3. Carfì A, Antocicco M, Brandi V, Cipriani C, Fiore F, Mascia D, Settanni S, Vetrano DL, Bernabei R, Onder G. Characteristics of adults with Down syndrome: prevalence of age-related conditions. Front Med (Lausanne) 2014;1:51
4. De Benedittis D, Fianchi L, Niscola P, Piccioni A, Di Veroli A, Campagna A, Mancini S, Villiva N, Mohamed S, Carmosino I, Criscuolo M, Fenu S, Aloe Spiriti MA, Buccisano F, Breccia M, Mancini M, Latagliata R. Myelodysplastic syndromes with isolated 20q deletion: a new clinical-biological entity? Blood 2018;132(Suppl 1):5516
5. McLean S, McHale C, Enright H. Hematological abnormalities in adult patients with Down’s syndrome. Ir J Med Sci 2009;178:35-38.